Accession Number: | 0001209191-14-054884 |
Date: | 2014-08-27 |
Issuer: | VERTEX PHARMACEUTICALS INC / MA (VRTX) |
Original Submission Date: |
BOGER JOSHUA S
C/O VERTEX PHARMACEUTICALS INCORPORATED
50 NORTHERN AVENUE
BOSTON, MA 02210
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|---|---|---|---|---|---|---|---|---|
COMMON STOCK | 2014-08-27 | M | 5,200 | a | $11.27 | 344,095 | direct | ||
COMMON STOCK | 2014-08-27 | S | 4,700 | d | $93.25 | 339,395 | direct | ||
COMMON STOCK | 2014-08-27 | S | 500 | d | $93.91 | 338,895 | direct | ||
COMMON STOCK | 2014-08-27 | 0 | $0.00 | 300,000 | indirect | f5 | |||
COMMON STOCK | 2014-08-27 | 0 | $0.00 | 13,286 | indirect |
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|---|---|---|---|---|---|---|---|---|---|---|---|
STOCK OPTION (RIGHT TO BUY) | 11.27 | 2014-08-27 | deemed execution date | M | 5,200 (d) | 2014-10-06 | common stock 5,200 | $11.27 | 26,500 | direct |
ID | footnote |
---|---|
f1 | transaction made pursuant to dr. boger's company approved trading plan under rule 10b5-1. |
f2 | open market sales reported on this line occurred at a weighted average price of $93.25 (range $92.77 to $93.75). |
f3 | dr. boger undertakes to provide (upon request by the sec staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. |
f4 | open market sales reported on this line occurred at a weighted average price of $93.91 (range $93.78 to $94.07). |
f5 | common stock held in grantor retained annuity trusts. |
f6 | fully vested. |